Business description: Bruker Corporation

Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic solutions. The Company's segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). Its BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research and development solutions in chemical research fields. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and others.

Number of employees: 11,085

Sales by Activity: Bruker Corporation

Fiscal Period: December 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

BSI CALID

- 822M 960M 1.09B 1.21B

BSI Nano

698M 787M 942M 1.1B 1.08B

BSI Bio Spin

- 697M 798M 906M 879M

BSI Life Science

1.51B - - - -

BEST

224M 237M 281M 283M 271M

Intersegment Revenue

-14M -12.3M -17M -14.1M -7.7M

Geographical breakdown of sales: Bruker Corporation

Fiscal Period: December 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

Europe

658M 592M 700M 873M 950M

United States

601M 696M 778M 938M 891M

Asia Pacific Excluding China

- 408M 461M 518M 553M

China

- 396M 528M 471M 476M

Germany

263M 247M 282M 311M 297M

Other

167M 190M 217M 254M 270M

Asia Pacific

729M - - - -

Executive Committee: Bruker Corporation

Manager TitleAgeSince
Chief Executive Officer 66 31/01/1991
Director of Finance/CFO 68 16/03/2018
Investor Relations Contact - 31/08/2024
Comptroller/Controller/Auditor 51 12/01/2025
General Counsel - 15/01/2022

Composition of the Board of Directors: Bruker Corporation

Director TitleAgeSince
Director/Board Member 79 31/01/2000
Chairman 66 31/01/1991
Director/Board Member 68 30/04/2007
Director/Board Member 71 05/08/2015
Director/Board Member 68 18/08/2015
Director/Board Member 69 10/11/2015
Director/Board Member 71 19/05/2016
Director/Board Member 66 31/12/2016
Director/Board Member 68 02/09/2020
Director/Board Member 59 17/02/2025

Shareholders: Bruker Corporation

NameEquities%Valuation
26.54 %
40,405,620 26.54 % 1 483 M $
Orbis Investment Management Ltd.
9.984 %
15,197,866 9.984 % 558 M $
Orbis Investment Management Ltd.
9.793 %
14,906,730 9.793 % 547 M $
Pallas Capital Advisors LLC
6.229 %
9,481,821 6.229 % 348 M $
Vanguard Portfolio Management LLC
3.19 %
4,855,915 3.19 % 178 M $
NameEquities%Valuation
Fidelity Management & Research Co. LLC
569.09 %
15,706,800 569.09 % 4 605 M $
BlackRock Fund Advisors
383.98 %
10,597,891 383.98 % 3 107 M $
Franklin Advisers, Inc.
90.92 %
2,509,404 90.92 % 736 M $
Morgan Stanley & Co. LLC
61.29 %
1,691,654 61.29 % 496 M $
BofA Securities, Inc.
36.02 %
994,014 36.02 % 291 M $

Company details: Bruker Corporation

Bruker Corp.

40 Manning Road

01821, Billerica

+978 663 3660

http://www.bruker.com
address Bruker Corporation(BRKR)

Group companies: Bruker Corporation

NameCategory and Sector
Medical Specialties
Medical Specialties
Medical Specialties
Medical Specialties
Telecommunications Equipment

Other Advanced Medical Equipment & Technology

Change 5d. change 1-year change 3-years change Capi.($)
+3.37%+17.56%+10.99%-39.41% 6.59B
+1.86%-1.62%+6.15%-12.48% 168B
+2.77%-4.42%-23.16%+41.33% 149B
+0.22%-4.63%-17.07%-26.74% 118B
+1.35%-3.21%-47.33%+1.58% 79.33B
+3.21%-3.69%+6.75%-10.46% 44.43B
+0.98%-3.69%-30.52%-36.94% 44.14B
+1.26%+2.38%-4.30%+29.49% 34.17B
+1.71%-3.82%-2.17%-11.33% 31.5B
-1.67%-1.19%-25.72%-45.27% 30.12B
Average +1.54%+0.53%-12.64%-11.02% 70.51B
Weighted average by Cap. +1.60%-2.82%-14.38%-2.90%
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
43.27USD
Average target price
49.15USD
Spread / Average Target
+13.60%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. BRKR Stock
  4. Company Bruker Corporation